News Image

Nuvectis Pharma to Participate in the 37th Annual Roth Conference

Provided By GlobeNewswire

Last update: Mar 14, 2025

FORT LEE, NJ, March 14, 2025 (GLOBE NEWSWIRE) -- Nuvectis Pharma, Inc. (“Nuvectis”, “Company”), a biopharmaceutical company focused on the development of innovative precision medicines for the treatment of serious conditions of unmet medical need in oncology, today announced that Ron Bentsur, Chairman and Chief Executive Officer, will participate in a fireside chat at the 37th Annual Roth Conference taking place March 17th-19th in Dana Point, California.

Read more at globenewswire.com

NUVECTIS PHARMA INC

NASDAQ:NVCT (6/10/2025, 1:42:40 PM)

8.97

+0.12 (+1.36%)



Find more stocks in the Stock Screener

Follow ChartMill for more